(Q79245436)

English

Comparison of alpha/beta estimates from homogeneous (individual) and heterogeneous (population) tumor control models for early stage prostate cancer

scientific article published on 01 October 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14596319%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Comparison of alpha/beta estimates from homogeneous (individual) and heterogeneous (population) tumor control models for early stage prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14596319%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Marco Carlone

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14596319%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

David Wilkins

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14596319%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Balazs Nyiri

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14596319%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Peter Raaphorst

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14596319%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14596319%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

number of pages

17

1 reference

based on heuristic

inferred from page(s)

Medical Physics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14596319%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14596319%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14596319%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

2832-2848

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14596319%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

Optimum parameters in a model for tumour control probability including interpatient heterogeneity

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor.

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

Is the alpha/beta for prostate tumors really low? In regard to Fowler et al., IJROBP 2001;50:1021-1031.

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

A calculation of the relative biological effectiveness of 125I and 103Pd brachytherapy sources using the concept of proximity function

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

Relative biological effectiveness enhancement of a 125I brachytherapy seed with characteristic x rays from its constitutive materials

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

The clinical significance of ratios of radiobiological parameters

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

Toward optimal external-beam fractionation for prostate cancer

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

Is alpha/beta for prostate tumors really low?

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

Fractionation and protraction for radiotherapy of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

How low is the alpha/beta ratio for prostate cancer?

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

Incorporating biologic measurements (SF2, CFE) into a tumor control probability model increases their prognostic significance: a study in cervical carcinoma treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

Tumour control probability: a formulation applicable to any temporal protocol of dose delivery.

1 reference

https://api.crossref.org/works/10.1118%2F1.1612946

21 January 2018

Identifiers

10.1118/1.1612946

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14596319%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14596319%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79245436&oldid=2098375762"